Modelling the long-term cost-effectiveness of riluzole for the treatment of amyotrophic lateral sclerosis

Manouche Tavakoli*, Huw T.O. Davies, M. Malek

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Modelling the long-term cost-effectiveness of riluzole for the treatment of amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Mathematics

Economics, Econometrics and Finance

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences